AGTR1 and endothelial dysfunction: Moreover, these individuals may benefit from the initiation of pharmacological treatments such as ACE inhibitors and angiotensin II type 1 receptor antagonists capable to ameliorate endothelial dysfunction and, possibly, to reduce the progression to heart failure [42–51].